Please login to the form below

Not currently logged in
Email:
Password:

Yasuchika Hasegawa

This page shows the latest Yasuchika Hasegawa news and features for those working in and with pharma, biotech and healthcare.

Takeda CEO admits to Blopress mis-marketing

Takeda CEO admits to Blopress mis-marketing

Campaign used graph indicating drug was superior to Pfizer’s Norvasc. Takeda's chief executive Yasuchika Hasegawa has admitted the company may have used "inappropriate" language in its marketing of blood ... The mis-marketing stemmed from a trial

Latest news

  • Takeda appoints GSK's Weber as chief operating officer Takeda appoints GSK's Weber as chief operating officer

    Current president and CEO Yasuchika Hasegawa is expected to be named chairman and interim CEO at Takeda in June, but could hand over the reins within the following few months if ... 67-year-old Hasegawa started the search for a new CEO last year.

  • Takeda buys Nycomed and names CEO

    Yasuchika Hasegawa, president and CEO of Takeda, said: "Partnering the two organisations will have complementary effects and further increase our potential to become a truly global pharmaceutical company.".

  • IBS drug approved in the US

    Yasuchika Hasegawa, president of Takeda, said: "This additional indication for Amitiza will help Takeda further enhance our position in the US primary care and GI speciality markets.".

  • Lundbeck and Takeda form US and Japan CNS alliance

    Other financial details were undisclosed. Yasuchika Hasegawa, president and CEO of Takeda, said: "We are delighted to have reached an agreement with one of the strongest global players in central nervous

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Takeda appoints Christophe Weber as its new CEO Takeda appoints Christophe Weber as its new CEO

    firm. This will become effective from April 1 this year. He will take over from the long-standing Yasuchika Hasegawa, who will become the new chairman of the board. ... Weber, formerly of GlaxoSmithKline, said: “First, I would like to thank Yasuchika

  • Takeda appoints new financial head Takeda appoints new financial head

    He will lead the integration and leadership of the finance functions across Takeda and will report to the company's president and CEO Yasuchika Hasegawa. ... senior leadership team at Takeda,” said Hasegawa.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics